HONG KONG – Scientists at the University of Hong Kong (HKU) have successfully synthesized teixobactin, a recently discovered antibiotic that is considered to be a breakthrough in antibacterial drug research.
HONG KONG – A new Japanese study of the effects of environmental and genetic influences on individual differences in proteomics and metabolomics has identified biomarkers for early disease prevention and diagnosis, through the identification and quantification of blood metabolites.
HONG KONG – A new Japanese study of the effects of environmental and genetic influences on individual differences in proteomics and metabolomics has identified biomarkers for early disease prevention and diagnosis, through the identification and quantification of blood metabolites.
HONG KONG — A novel small-molecule Wnt inhibitor possessing the potential to eradicate colorectal cancer stem cells (CSCs) may provide a new therapeutic option for patients with drug-refractory colorectal cancer, a team of Japanese researchers reported in the Aug. 26, 2016, edition of Nature Communications.
HONG KONG – A novel small-molecule Wnt inhibitor possessing the potential to eradicate colorectal cancer stem cells (CSCs) may provide a new therapeutic option for patients with drug-refractory colorectal cancer, a team of Japanese researchers reported in the Aug. 26, 2016, edition of Nature Communications.
HONG KONG – A protein that promotes angiogenesis can successfully be used to treat acute myocardial infarction (MI) in mice, offering the prospect of heart bypass without the need for surgery. The findings of a new collaborative Chinese/U.S. study were reported Aug. 11, 2016, in PLOS Biology.
HONG KONG – A protein that promotes angiogenesis can successfully be used to treat acute myocardial infarction (MI) in mice, offering the prospect of heart bypass without the need for surgery.
HONG KONG – A modified version of the revolutionary gene-editing system known as clustered regularly interspaced short palindromic repeats – cellular apoptosis susceptibility protein (CRISPR/Cas), allows researchers to perform DNA substitutions without actually cleaving the DNA, according to a new Japanese study led by researchers at the University of Kobe.
